News & Conferences

04/17/2024 News

Our innovative nanoenzalutamide tablet development is strengthened by the recent decision of the European Patent Office

We're thrilled to share our latest news!

01/16/2024 News

ONConcept® has successfully completed the pivotal BE study for Nilotinib

back-to-top